These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23380655)

  • 1. Proteomics as a novel HIV immune monitoring tool.
    Stein DR; Burgener A; Ball TB
    Curr Opin HIV AIDS; 2013 Mar; 8(2):140-6. PubMed ID: 23380655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
    Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
    AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):27-49. PubMed ID: 18388299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal innate immunity as a determinant of HIV susceptibility.
    Iqbal SM; Kaul R
    Am J Reprod Immunol; 2008 Jan; 59(1):44-54. PubMed ID: 18154595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
    Pantaleo G; Koup RA
    Nat Med; 2004 Aug; 10(8):806-10. PubMed ID: 15286782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring cellular immune markers in HIV infection: from activation to exhaustion.
    Sauce D; Elbim C; Appay V
    Curr Opin HIV AIDS; 2013 Mar; 8(2):125-31. PubMed ID: 23380653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17 cells, HIV and the gut mucosal barrier.
    Dandekar S; George MD; Bäumler AJ
    Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-host interactions in paediatric HIV-1 infection.
    De Rossi A
    Curr Opin HIV AIDS; 2007 Sep; 2(5):399-404. PubMed ID: 19372918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biology in the development of HIV vaccines.
    Haddad EK; Pantaleo G
    Curr Opin HIV AIDS; 2012 Jan; 7(1):44-9. PubMed ID: 22156842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whey acidic proteins (WAPs): novel modulators of innate immunity to HIV infection.
    Reading JL; Meyers AF; Vyakarnam A
    Curr Opin HIV AIDS; 2012 Mar; 7(2):172-9. PubMed ID: 22274658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A look at HIV journey: from dendritic cells to infection spread in CD4⁺ T cells.
    Blanchet F; Moris A; Mitchell JP; Piguet V
    Curr Opin HIV AIDS; 2011 Sep; 6(5):391-7. PubMed ID: 21743320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
    Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
    Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.
    Andersson KM; Stover J
    Vaccine; 2011 Aug; 29(36):6092-9. PubMed ID: 21703322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and specific mucosal immunity: workshop 4B.
    Challacombe SJ; Fidel PL; Tugizov S; Tao L; Wahl SM
    Adv Dent Res; 2011 Apr; 23(1):142-51. PubMed ID: 21441496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
    Girard MP; Osmanov S; Assossou OM; Kieny MP
    Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV/AIDS vaccines: heading for new vaccine approaches?].
    Girard MP
    Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting HIV-1 innate immune responses therapeutically.
    Ellegård R; Shankar EM; Larsson M
    Curr Opin HIV AIDS; 2011 Sep; 6(5):435-43. PubMed ID: 21734566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.